Invention Grant
- Patent Title: Methionine adenosyltransferase 2a (MAT2A) inhibitors and uses thereof
-
Application No.: US18509658Application Date: 2023-11-15
-
Publication No.: US11999713B2Publication Date: 2024-06-04
- Inventor: Chiachun Chen , Xiao Ding , Xiaosong Liu , Feng Ren , Hailong Wang
- Applicant: Insilico Medicine IP Limited
- Applicant Address: HK Hong Kong
- Assignee: INSILICO MEDICINE IP LIMITED
- Current Assignee: INSILICO MEDICINE IP LIMITED
- Current Assignee Address: HK Hong Kong
- Agency: WILSON SONSINI GOODRICH & ROSATI
- Priority: WO TCN2021125035 2021.10.20 WO TCN2022116510 2022.09.01
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D239/95 ; C07D403/04 ; C07D471/04 ; C07D487/04
Abstract:
Described herein are MAT2A inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with MAT2A.
Public/Granted literature
- US20240132465A1 METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF Public/Granted day:2024-04-25
Information query
